The nucleolar enzyme sirtuin 7 (SIRT7) promotes cancer progression in certain malignancies, likely in part by controlling ribosome biosynthesis. Recently, we discovered that SIRT7 destabilizes the cyclin dependent kinase inhibitor 2A (CDKN2A, known as ARF) within the nucleolus, aiding cancer progression. We propose that targeting nucleolar SIRT7 offers promise for new anti-cancer therapies.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11259054 | PMC |
| http://dx.doi.org/10.1080/23723556.2024.2381287 | DOI Listing |
Publication Analysis
Top Keywords
cancer progression
8
sirt7-nucleolus connection
4
connection cancer
4
cancer arf
4
arf enters
4
enters fray
4
fray nucleolar
4
nucleolar enzyme
4
enzyme sirtuin
4
sirtuin sirt7
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!